|Bid||32.7500 x 1300|
|Ask||32.7700 x 1300|
|Day's Range||32.6200 - 33.0800|
|52 Week Range||27.6000 - 56.4400|
|PE Ratio (TTM)||420.08|
|Dividend & Yield||1.36 (4.17%)|
|1y Target Est||N/A|
Alder stock dove to a nearly three-year low Tuesday despite strong data in a Phase 3 migraine trial, making it competitive with Lilly, Amgen and Teva.
Xenon Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. said premarket Tuesday that their mid-stage nerve pain drug missed its primary endpoint and secondary endpoints. Xenon shares plummeted ...
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.